lorazepam has been researched along with CJD (Creutzfeldt-Jakob Disease) in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rathinakumar, H | 1 |
| Schutz, C | 1 |
| Smith, R | 1 |
| French, BR | 1 |
| Mhadi, E | 1 |
| Brandt, K | 1 |
1 other study available for lorazepam and CJD (Creutzfeldt-Jakob Disease)
| Article | Year |
|---|---|
Creutzfeldt-Jakob disease presenting as catatonia with desaturation on lorazepam challenge.
Topics: Catatonia; Creutzfeldt-Jakob Syndrome; Humans; Lorazepam | 2022 |